Escalon Medical Corp. (NASDAQ: ESMC) today announced its operating results for the fiscal year ended September 30, 2014.
Month: September 2014
Iluvien Update 8: Alimera Sciences Receives FDA Approval of Iluvien for Treatment of DME
After several attempts to gain approval for its NDA for Ilunien, the FDA has finally seen the light (after approval in the UK, Germany, and marketing or pending approvals in seventeen other EU countries).
I first began writing about Iluvien in July 2010 – see my comprehensive writeup about the technology behind this and other sustained delivery drug systems – Iluvien and the Future of Ophthalmic Drug Delivery Systems. In addition I have written about the products progress in seven updates, the latest in August 2012, Iluvien Update 7: Alimera Sciences to Re-File for FDA Approval of Iluvien for (Read more...)
James V. Mazzo indicted for insider trading
A federal grand jury indicted James V. Mazzo, former CEO of Advanced Medical Optics, on insider trading charges, according to a press release issued by the U.S. Department of Justice. Mazzo’s indictment was added to the initial 2012 indictment that named former professional baseball player, Douglas V. DeCinces, and his two associates: David Parker of Provo, Utah, a friend and business partner of DeCinces; and Fred Scott Jackson of Newport Beach, Calif., a friend and real estate attorney of DeCinces.
Suprachoroidal micro-shunt safely, effectively lowers IOP
LONDON – A study of patients implanted with the CyPass suprachoroidal micro-shunt showed the device safely and effectively lowered IOP, according to Magda Rau, MD.In a video perspective at the European Society of Cataract and Refractive Surgeons meeting here, Rau discusses results of the procedure combined with cataract surgery and as a single procedure.
Nicox Glaucoma Drug Effective in Late-Stage Studies
French pharmaceutical firm Nicox unveiled positive topline Phase 3 results for its glaucoma drug and said, if approved by regulators, the product could reach peak annual sales of over $1 billion worldwide. Reuters Health Information
Scientists discover new clues about drug used in treating blood cancer
Keck Medicine of USC scientists have discovered new clues about a drug instrumental in treating a certain blood cancer that may provide important targets for researchers searching for cures.
Bausch + Lomb announces positive phase 3 data for sub-micron loteprednol etabonate
Bausch + Lomb announced that its twice-daily sub-micron loteprednol etabonate was superior to placebo in eliminating inflammation and pain after cataract surgery.If approved, the novel gel will be the first twice-daily ophthalmic steroid, according to …
Artificial cornea to help address corneal blindness
LONDON – At the European Society of Cataract and Refractive Surgeons meeting in London, Jorge L. Alio, MD, discusses early clinical experience with the KeraKlear non-penetrating artificial cornea. The artificial cornea presents an opportunity when human cornea tissue transplant is either unavailable or keratoplasty cannot be performed.
Researchers awarded $16 million NIMH grant to create genetic resource for psychiatric disorders
A multi-institutional team of researchers studying schizophrenia and bipolar disorder has been awarded a $16 million grant from the National Institute of Mental Health to create the most extensive genetic resource to date for these two devastating psyc…
New clinical applications for assessing ‘higher-order’ visual abnormalities
A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities.
Two genes that cause pediatric glaucoma increases risk of future stroke up to ten times
Every year in Canada about 50,000 people suffer from a stroke, caused either by the interruption of blood flow or uncontrolled bleeding in the brain. While many environmental risk factors exist, including high blood pressure and smoking, stroke risk is…
Retinal tumors in young children caused by a single, genetic change
Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.
Patients Self-Monitor With Wearable Diagnostics
New wearable tracking technology will allow continuous monitoring and novel opportunities for diagnosis, say technologists. Medscape Medical News
Immediate Sequential Cataract Surgery Reduces Revenue
Lower current reimbursement rates for immediate sequential cataract surgery (ISCS) compared with delayed sequential cataract surgery (DSCS) result in lower revenue for ophthalmologists, according to a new cost analysis. Reuters Health Information
Bilateral toric IOL improved spectacle independence vs. bilateral control implantation
Bilateral toric IOL implantation led to greater spectacle independence for distance vision compared with bilateral control IOL implantation in patients with cataract and corneal astigmatism, according to study data.Researchers included 86 patients with…
Bausch + Lomb, Nicox announce positive phase 3 results for Vesneo
Bausch + Lomb, a subsidiary of Valeant, and Nicox announced that pivotal phase 3 studies conducted with Vesneo yielded positive top-line results, according to a joint press release.Vesneo (latanoprostene bunod; previously known as BOL-303259-X and NCX …
GuideWell, OSI partner to provide affordable, quality health care to growing Hispanic market
GuideWell Mutual Holding Corporation and Organizacion Sanitas Internacional have established a strategic alliance to create a new company with the purpose of offering a culturally relevant health delivery model that provides affordable and quality heal…
Elsevier honored at BMA Medical Book Awards ceremony
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association’s annual BMA Medical Book Awar…
Ivantis secures additional $25 million in Series B financing
Ivantis announced it has secured an additional $25 million in its Series B financing, bringing the total Series B financing to $71 million, according to a company press release. Investors included in the latest closure are Foresite Capital, New Enterpr…
Researchers reveal why RB1 gene mutations primarily cause retinoblastomas in children
Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children.